Sign inJoin waitlistJoin the waitlist

Maria Galkin

Physician · Lahey Clinic

Credentials: · · · · ·

History

Lahey Clinic
2023–Present

University of California-Davis
2019–2021
Internal Medicine
University of California Davis Health
2016–2019
Temple University School of Medicine
2012–2016

Research

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy
Core evidence · 2019 · First of 2 authors · 18 citations
Breast cancer-specific survival in patients with HER2-positive, node-negative T1a and T1b breast cancer
Cancer Treatment and Research Communications · 2018 · 5 citations
A phase II trial of decitabine, bortezomib and pegylated liposomal doxorubicin for the treatment of relapsed or refractory AML
Leukemia Research Reports · 2023 · 4 citations

Brian Jonas
2 papers
AF
Amir Farid
1 paper · 1 as a resident
Ezra Amsterdam
1 paper
Helen Chew
1 paper
Joseph Tuscano
1 paper
LP
Laura Potter
1 paper · 1 as a resident
Mamta Parikh
1 paper · 1 as a fellow
Neil Beri
1 paper · 1 as a fellow
William Lewis
1 paper

Clinical trials

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2034